It is dynamite at times for short term traders but the overall picture for the company holds enormous promise.It will whip about but the asset appears solid and while management can hype they do get the job done.
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025
OAR Chris Judd's Talk Ya Book: Orthocell building on 'enormous potential' with steady growth - and US push to come